The Clinical Utility of Korean Bayley Scales of Infant and Toddler Development-Ⅲ - Focusing on using of the US norm -

2017 ◽  
Vol 36 (1) ◽  
pp. 81 ◽  
Author(s):  
Yoo Jin Lim ◽  
Hee Jeong Bang ◽  
Soon Hang Lee
2020 ◽  
Vol 91 (7) ◽  
pp. 592-596
Author(s):  
Quinn Dufurrena ◽  
Kazi Imran Ullah ◽  
Erin Taub ◽  
Connor Leszczuk ◽  
Sahar Ahmad

BACKGROUND: Remotely guided ultrasound (US) examinations carried out by nonmedical personnel (novices) have been shown to produce clinically useful examinations, at least in small pilot studies. Comparison of the quality of such exams to those carried out by trained medical professionals is lacking in the literature. This study compared the objective quality and clinical utility of cardiac and pulmonary US examinations carried out by novices and trained physicians.METHODS: Cardiac and pulmonary US examinations were carried out by novices under remote guidance by an US expert and independently by US trained physicians. Exams were blindly evaluated by US experts for both a task-based objective score as well as a subjective assessment of clinical utility.RESULTS: Participating in the study were 16 novices and 9 physicians. Novices took longer to complete the US exams (median 641.5 s vs. 256 s). For the objective component, novices scored higher in exams evaluating for pneumothorax (100% vs. 87.5%). For the subjective component, novices more often obtained clinically useful exams in the assessment of cardiac regional wall motion abnormalities (56.3% vs. 11.1%). No other comparisons yielded statistically significant differences between the two groups. Both groups had generally higher scores for pulmonary examinations compared to cardiac. There was variability in the quality of exams carried out by novices depending on their expert guide.CONCLUSION: Remotely guided novices are able to carry out cardiac and pulmonary US examinations with similar, if not better, technical proficiency and clinical utility as US trained physicians, though they take longer to do so.Dufurrena Q, Ullah KI, Taub E, Leszczuk C, Ahmad S. Feasibility and clinical implications of remotely guided ultrasound examinations. Aerosp Med Hum Perform. 2020; 91(7):592–596.


2021 ◽  
pp. 105416
Author(s):  
L.W.Y. McLester-Davis ◽  
A. Shankar ◽  
L.A. Kataria ◽  
A.G. Hidalgo ◽  
E.D. van Eer ◽  
...  

2018 ◽  
Vol 9 ◽  
Author(s):  
Suman Ranjitkar ◽  
Ingrid Kvestad ◽  
Tor A. Strand ◽  
Manjeswori Ulak ◽  
Merina Shrestha ◽  
...  

2009 ◽  
Vol 26 (2) ◽  
pp. 154-164 ◽  
Author(s):  
Angela Kinsella-Ritter ◽  
Frances L. Gibson ◽  
Shirley Wyver

AbstractThe Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) is a standardised assessment used to assess the developmental functioning of infants and young children from 1 month to 42 months of age (Bayley, 2006a). The Bayley scales are recognised internationally as one of the most comprehensive developmental assessment instruments (Sattler & Hoge, 2006) used to examine the major facets of a young child's development (Bayley, 2006a). The primary purpose of the Bayley-III is to identify children with developmental delay and to provide information for intervention implementation (Bayley, 2006a). The domains of early development covered increased from two to five including cognition, language, motor, social-emotional and adaptive behaviour with the publication of the third edition (Bayley, 2006a). While the original Bayley scales were predominately used by psychologists, publication of later editions led to accredited use, within the Australian and New Zealand context, by developmental paediatricians, occupational therapists, physiotherapists and speech pathologists (Bayley, 1969; Bayley 1992; Pearson Clinical and Talent Assessment, 2009). Although the Bayley-III is more comprehensive and a broader range of professionals now use the scales little is known about the clinical application. The current study aimed to explore the use of the Bayley-III in practice and views on the current US norms. An online survey was conducted and the findings revealed that the majority of respondents were interested in Australian local norms; the predominant age range assessed was the 24- to 42-month-old group and the most common clinical group seen and assessed was children presenting with global developmental delay. While the majority of the respondents used the Bayley-III approximately once a month or more, at least one third used it less often. However anticipated use over the next 12 months indicated a notable increase from 30% currently using it once or twice weekly up to 65%.


1996 ◽  
Vol 42 (5) ◽  
pp. 809-812 ◽  
Author(s):  
W D LeBar

Abstract Chlamydia trachomatis infections are among the most common sexually transmitted infections in the US today. One of the keys to the prevention of C. trachomatis infection rests on the ability to make this diagnosis on the basis of accurate laboratory testing. For many years the standard for diagnosis of C. trachomatis infections has been isolation in tissue culture. Numerous nonculture methods, including enzyme immunoassay, have been used as an alternative to cell culture. The performance characteristics of these tests have all been compared with a standard, cell culture, which at best will detect 90% of positive specimens. Nucleic acid amplification techniques, including PCR and ligase chain reaction, have been recently introduced. The advantage of these tests is their ability to detect 10-20% more positive specimens when compared with culture or confirmed nonculture methods performed with a single specimen. The sensitivity of amplified tests also allows us to test specimens from multiple sites (endocervix, urethra, urine), which expands our standard from an infected sample to detection of an infected patient. Tests based on amplified nucleic acid technology have greatly improved our ability to diagnose urogenital C. trachomatis infection. The use of an expanded standard will help us accurately define the true performance and clinical utility of nonculture Chlamydia diagnostic tests.


2017 ◽  
Vol 27 (8) ◽  
pp. 1447-1454 ◽  
Author(s):  
Maia M. Noeder ◽  
Beth A. Logan ◽  
Kari L. Struemph ◽  
Nancy Condon ◽  
Isabel Mueller ◽  
...  

AbstractObjectiveStandardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population.Study designASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition.ResultsWhen ASQ-3 screening failure was defined as ⩾1 SD below the normative mean, specificity (⩾81.9%) and negative predictive value (⩾81.0%) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6%), increased with age for communication (35.7–100%), and generally decreased with age for problem solving (73.1–50.0%). When ASQ-3 screening failure was defined as ⩾2 SD below the normative mean, specificity (⩾93.6%) and positive predictive value (⩾74.5%) were generally high across ASQ-3 areas, but sensitivity was low (31.1%) to fair (62.8%). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone.ConclusionsThe ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ⩾1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.


Sign in / Sign up

Export Citation Format

Share Document